|Articles|July 6, 2017
Gustave Roussy Selects TrialMaster EDC to Support Cancer Research
Advertisement
Gustave Roussy-cancer research institute in Europe, focusing on patient care, research, and teaching-announced it has selected, and signed a five-year commitment to, TrialMaster electronic data capture (EDC) technology from global provider of clinical data management technology, OmniComm Systems, Inc. TrialMaster will support Gustave Roussy-sponsored clinical trials in oncology.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Global Breast Cancer Trials Show Progress in Diversity, But Gaps Remain
2
ACT Brief: AI Innovations, Vision Trial Breakthroughs, and a Major Industry Acquisition
3
Bringing Clinical Trials Into the Digital Era with eConsent
4
A Look Back: AI and Pragmatic Trials Took Center Stage at SCOPE Summit 2025
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
